The remaining authors declare which the analysis was executed within the absence of any business or financial relationships that would be construed as a possible conflict of interest. Inhibition of galectin-3 with GB1211 was not connected to any therapy- or dose-connected developments and there were no clinically substantial security or https://oswaldo949owq3.wikicarrier.com/user